FCGR2B and systemic lupus erythematosus: Of interest, Fcgr2b-/- lupus-prone mice treated with dexamethasone or Dex-NPs exhibited less severe renal interstitial inflammation and lower glomeruli with mesangial expansion (Figure 9A, third and fourth rows, and Figure 9B,C).